Zobrazeno 1 - 10
of 55
pro vyhledávání: '"D, Assar"'
Autor:
Ariane Lemieux, S. Shiva Patlolla, Fuad Habash, Detlef Wencker, Parag Kale, Jeffrey M. Schussler, Manish D. Assar
Publikováno v:
HeartRhythm Case Reports. 8:790-792
Autor:
Patrick Strickland, Shiva Patlolla, Adam Sundholm, Jennifer Rasmussen-Winkler, Manish D. Assar
Publikováno v:
Heart Rhythm. 20:S416-S417
Publikováno v:
Heart Rhythm. 20:S426
Publikováno v:
Journal of Cardiac Failure. 29:635
Publikováno v:
Dermatologic Surgery. 46:612-615
Mohs micrographic surgery, excisional surgery, and electrodessication and curettage (EDC) are common dermatologic procedures that often use electrodessication through hyfrecators to achieve hemostasis. According to in vitro studies, electrodessicatio
Publikováno v:
Cardiovascular Pathology. 56:107390
Described herein is a 71-year-old man who underwent orthotopic heart transplant (OHT) for chronic severe heart failure secondary to cardiac sarcoidosis (CS) devoid of non-caseating granulomas but nevertheless characteristic of CS. Clinically, his hea
Publikováno v:
Baylor University Medical Center Proceedings. 31:502-505
Few cases of coincident takotsubo cardiomyopathy and complete heart block (CHB) have been reported. A 62-year-old woman presented with typical chest pain and was found to have CHB with a left ventricular ejection fraction of 35% and apical ballooning
Autor:
Timothy Ball, Peter A. McCullough, Manish D. Assar, Robert C. Stoler, Jong Mi Ko, Anupama Vasudevan
Publikováno v:
Baylor University Medical Center Proceedings. 31:407-413
Transcatheter aortic valve implantation (TAVI) is growing in utilization in the USA, and atrioventricular heart block is a common complication of the procedure. In patients with conduction system changes following TAVI, there are no clear guidelines
Publikováno v:
Proc (Bayl Univ Med Cent)
Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR p
Autor:
David P. Mason, Shelley A. Hall, Kathleen Kopecky, Joost Felius, Jose C. Mendez, Manish D. Assar, Aasim Afzal, Amarinder Bindra
Publikováno v:
Pacing and Clinical Electrophysiology. 41:93-95
Ventricular tachycardia (VT) commonly occurs in patients with ischemic or nonischemic cardiomyopathy and requires antiarrhythmic drugs, ablation, or advanced circulatory support. However, life-threatening VT may be refractory to these therapies, and